×

ILLINOIS DEPARTMENT OF PUBLIC HEALTH URGES PUBLIC VILIGANCE AS FLU AND RESPIRATORY VIRUS CASES RISE

By Mark Wells Feb 5, 2025 | 11:54 AM

The Illinois Department of Public Health (IDPH) has reported an uptick in the state’s overall respiratory illness level, moving from Moderate to High, primarily due to a significant increase in emergency department (ED) visits and hospital admissions for flu.

 

 

“IDPH is closely monitoring seasonal viruses during this respiratory season,” said IDPH Director Dr. Sameer Vohra. “Flu is circulating widely across Illinois. I advise individuals over 65, young children, those with chronic diseases, and immunocompromised individuals to utilize all preventive measures. If flu-like symptoms develop, contact your healthcare provider promptly, as antiviral medication is most effective when started within 48 hours of symptom onset.”

 

After experiencing a dip to Moderate in January, the state’s respiratory activity level has returned to High, driven by rising flu rates. The CDC categorizes respiratory activity levels as Minimal, Low, Moderate, High, and Very High, based on a range of respiratory illness data from emergency department visits.

 

Health officials emphasize that it’s not too late for unvaccinated individuals to receive flu vaccinations, as it typically takes about two weeks for full protection to develop. Vaccination now can help safeguard against illnesses throughout the ongoing cold and flu season.

 

Director Vohra encourages anyone experiencing respiratory symptoms—such as fever, runny nose, sore throat, or cough—to consider early testing and treatment, especially those at higher risk of severe illness. Those who are ill should take precautions to avoid spreading germs, such as self-isolating or wearing a mask.

 

Tragically, the IDPH Respiratory Illness Dashboard has reported five pediatric deaths this season due to flu, with additional fatalities from RSV and COVID-19. These incidents highlight the critical importance of vaccinations for children to prevent serious illness from these largely preventable diseases.

 

IDPH has released new FAQ documents on its website, offering guidance on vaccinations and testing for seasonal illnesses. The CDC has also launched a Respiratory Illness Data Channel providing county-specific information nationwide.

 

New vaccines for COVID-19 and flu have been approved, with recommendations for everyone over six months old to get vaccinated. The RSV vaccine is advised for individuals aged 75 and older and for those aged 60-74 who are at risk. Individuals who received an RSV shot last winter do not require another at this time. Pregnant individuals are encouraged to receive the RSV vaccine to protect their newborns.

 

COVID-19 treatment must be prescribed by a healthcare provider and initiated within 5–7 days after symptoms appear, particularly for those over 65 or at higher risk of severe illness. Free oral antivirals may be available for some Illinois residents through the Paxcess and Merck Helps programs.

 

Antiviral treatments for flu are most effective within 48 hours of symptom onset and are available only by prescription. At-risk individuals, including older adults and young children, should consult a healthcare provider for assessment and potential treatment as soon as possible.

 

COVID-19 testing locations can be found using the federal ICATT (Increasing Community Access to Testing) program’s testing locator.

 

Vaccines are widely available at pharmacies, hospitals, and community health clinics, with major pharmacy chains offering online appointment scheduling for vaccinations.

 

For assistance in finding a vaccine provider, visit www.vaccines.gov. IDPH also provides vaccine information for uninsured or underinsured individuals and for children eligible for the Vaccines for Children program through its Vaccine Locator Dashboard.

 

Adults without insurance can reach out to their local health department for options or contact free and charitable clinics or Community Health Centers for assistance.

Comments

Leave a Reply